World Heart Day: A Rapid Cardiac Solution

The Gatekeeper of Heart Health: Clinical Value of the Ck-Mb/CTnI/MYO Panel

As World Heart Day approaches, early Diagnosis and intervention for heart health are once again a global focus.Creatine Kinase MB (CK-MB), Cardiac Troponin I (CTnI), and Myoglobin (MYO) are regarded as the "golden triangle" for diagnosing myocardial injury. CTnI is a specific marker for myocardial infarction; CK-MB helps indicate re-infarction; and MYO rises rapidly in the initial stages of an attack, providing a critical window for very early diagnosis. Traditional testing processes are time-consuming, struggling to meet the urgent need for speed and efficiency in settings like emergency departments and primary care.

Lanmuo: Empowering Heart Health Testing with Technology, Redefining Standards

Addressing these clinical pain points, the new-generation Lanmuo Multi-Channel Immunofluorescence Detection System emerges as a powerful solution, offering outstanding advantages for rapid cardiac diagnosis:

Multi-Assay Testing, Efficient & Simultaneous: Leveraging multi-channel testing technology, it can simultaneously initiate tests for multiple different items like CK-MB, CTnI, and MYO on a single test card. One sample loading delivers multiple results concurrently within 15 minutes, significantly improving efficiency in differential diagnosis of chest pain in emergency settings.

Compact, Portable, Long-Lasting Battery: The device features a compact and lightweight design with a built-in, long-lasting battery, freeing it from reliance on a fixed power source. It operates reliably anywhere – from hospital ERs and primary care clinics to outdoor rescue scenarios and mobile medical vehicles – ensuring cardiac testing capability is "available everywhere."

Smart Barcode Scanning, Traceable Management: Supports rapid sample barcode identification via a scanner, automatically linking patient information with test results. This reduces manual entry errors and enables digital management and full traceability of sample information, aligning with smart healthcare trends.

Platform Versatility, One Device Multiple Uses: Lanmuo X is an open testing platform. Beyond the cardiac panel, it supports over 80 test items (e.g., heart failure markers, inflammation indicators, coagulation function), allowing flexible configuration based on clinical needs. This maximizes return on investment through its multi-function capability.

Multi-Scenario Application, Building a Comprehensive Heart Health Management System

Emergency Department / Chest Pain Centers: Rapidly screen patients with chest pain, providing immediate evidence for Acute Myocardial Infarction (AMI) diagnosis and seizing the golden treatment window.

Primary Care Institutions: Its portability and ease of use make it ideal for heart health screening in primary care, supporting tiered diagnosis and treatment.

Physical Exams & Health Management: Offers convenient annual heart health screening and dynamic monitoring for medium-to-high-risk groups.

Pre-hospital Care & Field Operations: The built-in battery and portable design enable key functionality even in outdoor or mobile scenarios lacking stable power sources.

Core Parameters:
Test Items: CK-MB, CTnI, MYO, and 80+ more items
Sample Type: Serum/Plasma/Whole Blood (requires only 50μL)
Detection Time: ≤15 minutes
Product Advantages: Multi-channel simultaneous detection, Compact & portable with built-in battery, Barcode scanning, Platform versatility

AEHEALTH LIMITED, is the fast growing POCT company. Manufacture and sales of rapid diagnostic reagents and related equipment in IVD field.

The product application is covering areas like small clinics, ambulances, customs, ICU, homes, natural disaster rescue, third- party laboratories, etc. To achieve the stability of quanlity control, Aehealth obtained multiple certifications like ISO13485 and CE MARK for the quality control management system.